(Q77057691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695796%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

review article

1 reference

title

Prostaglandin derivates as ocular hypotensive agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695796%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

A Alm

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695796%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695796%20AND%20SRC:MED&resulttype=core&format=json

Progress in Retinal and Eye Research

2 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695796%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695796%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695796%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

291-312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695796%20AND%20SRC:MED&resulttype=core&format=json

PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Properties of irin, a physiological constituent of the rabbit's iris

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Some differences in uveal reactions between cats and rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

CGRP(8-37) and CGRP(32-37) contract the iris sphincter in the rabbit eye: antagonism by spantide and GR82334.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

SMOOTH MUSCLE STIMULATING LIPIDS IN SHEEP IRIS. THE IDENTIFICATION OF PROSTAGLANDIN F 2A. PROSTAGLANDINS AND RELATED FACTORS 21.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Effect of topical phenylephrine on the permeability of the blood-aqueous barrier in man

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Chronic electrical stimulation of sympathetic nerves: effects on blood-aqueous barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Individual responsiveness to topical pilocarpine and the effects of variations in application technique

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Substance P: release on trigeminal nerve stimulation, effects in the eye

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Cholecystokinin causes contraction of the pupillary sphincter in monkeys but not in cats, rabbits, rats and guinea-pigs: antagonism by lorglumide

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Intraocular fluid dynamics. III. The site and mechanism of prostaglandin transfer across the blood intraocular fluid barriers

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Studies on a novel series of acyl ester prodrugs of prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Effects of topical PGF2 alpha on aqueous humor dynamics in cynomolgus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Increased intraocular pressure produced by prostaglandins E1 and E2 in the cat eye

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9 alpha,11 beta-PGF2 and PGF2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandins: Their Disappearance from and Release into the Circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

The effect of prostaglandin F2 alpha on trabecular outflow facility in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

The effects of prostaglandin F2 alpha in the human eye

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Effect of topical prostaglandin D2 on the aqueous humor dynamics in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Properties of human seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandin F2 alpha isopropyl ester versus iloprost phenacyl ester in rabbit and beagle eyes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Antagonist of platelet-activating factor prevents prostaglandin E2 induced ocular hypertension in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Effects of intracamerally infused prostaglandins on outflow facility in cynomolgus monkey eyes with intact or retrodisplaced ciliary muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandin F2 alpha-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

The effect of indomethacin 0.5% ophthalmic suspension in preventing surgically induced miosis during planned extracapsular cataract extraction

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Ocular responses to antidromic trigeminal stimulation, intracameral prostaglandin E1and E2, capsaicin and substance P

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Localisation of prostaglandin F2 alpha and E2 binding sites in the human eye

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Long-term effects of topically applied epinephrine on the blood-ocular barrier in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Effects of prostaglandin D2 and its analogue, BW245C, on intraocular pressure in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandin F-2 alpha functions as a local hormone on human airways

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

The effect of topical PGF2 alpha on uveoscleral outflow and outflow facility in the rabbit eye.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandin-induced iridial pigmentation in primates

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandin A2 increases uveoscleral outflow and trabecular outflow facility in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

The effect of adding prostaglandin F2 alpha-isopropylester to timolol in patients with open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Prostaglandin influences on intraocular pressure and pupil size

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

Marked differential effects of prostanoid metabolites on rabbit intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900003-7

7 January 2021

10.1016/S1350-9462(97)00003-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695796%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference